A surprising new finding from neuroscientists at the Medical University of South Carolina challenges the widely accepted belief that fish oil protects the brain. The research, published in Cell Reports, suggests that these ubiquitous supplements may actually interfere with the brain's ability to heal after repeated mild head injuries.
The discovery centers on a specific omega-3 component called eicosapentaenoic acid, or EPA. Unlike other fatty acids long known to benefit brain health, EPA appears to disrupt the biological processes that repair blood vessels following injury, particularly in people who experience multiple head traumas.
Neuroscientist Onder Albayram, who led the research team, notes the pressing relevance of these findings. Fish oil supplements have exploded in popularity, now appearing not just in capsule form but in everything from beverages to dairy alternatives and snack foods. Most people taking them have little idea what their long-term effects might be.
"Fish oil supplements are everywhere, and people take them for a range of reasons, often without a clear understanding of their long-term effects," Albayram said. The research represents the first investigation of its kind to examine how fish oil specifically affects brain recovery from injury.
The team conducted experiments on mice exposed to repeated mild head impacts while using fish oil supplements long-term. Animals that received the supplements showed worse performance on learning and spatial memory tasks. Brain tissue analysis revealed accumulation of tau protein, a hallmark of neurological damage, concentrated around blood vessels in the cortex.
The researchers also examined human brain cells in the laboratory. When cells were exposed to conditions that mimicked post-injury metabolism, EPA was associated with reduced ability to form new blood vessel networks and weakened barrier integrity, matching the problems observed in the animal studies.
To strengthen the translational connection, the team analyzed postmortem brain tissue from people diagnosed with chronic traumatic encephalopathy (CTE), a degenerative brain condition linked to repeated head injuries. The tissue showed evidence of disrupted fatty acid balance and impaired vascular function consistent with the EPA-linked vulnerability identified in their experiments.
Albayram emphasized that the findings should not be oversimplified into a universal warning. The harmful effects of EPA appear to depend on context: the presence of repeated brain injury, the duration of supplementation, and underlying metabolic conditions all matter.
"I am not saying fish oil is good or bad in some universal way," he said. "What our data highlight is that biology is context-dependent."
Another key difference emerged between types of omega-3 fatty acids. Docosahexaenoic acid, or DHA, is well established as beneficial for brain structure and function, incorporated directly into neuronal membranes. EPA, by contrast, follows a different metabolic pathway and does not integrate into brain tissue the same way. Its effects vary depending on concentration and biological conditions.
The research team, which included collaborators from Cold Spring Harbor Laboratory and other institutions, identified a phenomenon they call context-dependent metabolic vulnerability. In the injured brain, EPA appears to reprogram genetic activity in ways that suppress the body's natural repair mechanisms, reducing the expression of genes responsible for blood vessel stability and structural integrity.
Albayram cautioned that important limitations exist. The CTE tissue analysis revealed patterns but cannot definitively establish cause and effect. The experiments also could not account for all variables shaping how omega-3s behave in living people, including overall diet, general health status, and lifestyle factors.
Future research will focus on how EPA moves through the body, including its absorption, transport, and distribution. The team hopes their work prompts both clinicians and the general public to reconsider how and why they use omega-3 supplements, particularly among people at risk for repeated brain injury.
Author Jessica Williams: "This study cuts against the supplement industry's relentless marketing, but the real story is more nuanced and arguably more important: omega-3s aren't one-size-fits-all, and context matters hugely in neuroscience."
Comments